BIOMAT Database Logo BIOMAT Database Logo

[Clinical evaluation of S-6436 in adult patients with acute upper respiratory tract infections (author's transl)]. 1978

T Osawa, and T Kawai, and F Tabakotani, and T Tsuda, and Y Hamazaki, and H Maeda

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002506 Cephalexin A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

T Osawa, and T Kawai, and F Tabakotani, and T Tsuda, and Y Hamazaki, and H Maeda
[Clinical experience with S-6436 in patients with urinary tract infections (author's transl)].
October 1977, The Japanese journal of antibiotics,
T Osawa, and T Kawai, and F Tabakotani, and T Tsuda, and Y Hamazaki, and H Maeda
[Clinical experience with S-6436 in urinary tract infections (author's transl)].
October 1977, The Japanese journal of antibiotics,
T Osawa, and T Kawai, and F Tabakotani, and T Tsuda, and Y Hamazaki, and H Maeda
[Clinical studies on S-6436 in urinary tract infections (author's transl)].
June 1977, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
T Osawa, and T Kawai, and F Tabakotani, and T Tsuda, and Y Hamazaki, and H Maeda
[Clinical evaluation on S-6436 (author's transl)].
June 1977, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
T Osawa, and T Kawai, and F Tabakotani, and T Tsuda, and Y Hamazaki, and H Maeda
[Pharmacological and clinical studies on S-6436 in urinary tract infections (author's transl)].
June 1977, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
T Osawa, and T Kawai, and F Tabakotani, and T Tsuda, and Y Hamazaki, and H Maeda
[Clinical experience with S-6436 in acute pyelonephritis (author's transl)].
October 1977, The Japanese journal of antibiotics,
T Osawa, and T Kawai, and F Tabakotani, and T Tsuda, and Y Hamazaki, and H Maeda
[Clinical efficacy of S-6436 in urinary tract infection (author's transl)].
October 1977, The Japanese journal of antibiotics,
T Osawa, and T Kawai, and F Tabakotani, and T Tsuda, and Y Hamazaki, and H Maeda
[Clinical and pharmacological evaluation of S-6436 (long acting preparation of cephalexin) in urinary tract infections (author's transl)].
June 1977, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
T Osawa, and T Kawai, and F Tabakotani, and T Tsuda, and Y Hamazaki, and H Maeda
[Virology of acute upper respiratory tract infections (author's transl)].
March 1976, HNO,
T Osawa, and T Kawai, and F Tabakotani, and T Tsuda, and Y Hamazaki, and H Maeda
[Clinical evaluation of S-6436 in acute simple cystitis: A double blind comparative study of S-6436 and cephalexin (author's transl)].
June 1977, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Copied contents to your clipboard!